BNP PARIBAS ARBITRAGE/CALL/SARTORIUS STEDIM BIO/300/0.025/20.09.24 Share Price

Warrant

BB2NB

NLBNPFR1YEQ4

Market Closed - Euronext Paris 17:30:01 13/05/2024 BST
0.105 EUR -16.00% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/SARTORIUS STEDIM BIO/300/0.025/20.09.24
Current month-16.00%
1 month-77.89%
Date Price Change Volume
13/05/24 0.105 -16.00% 9
10/05/24 0.115 -8.00% 15
09/05/24 0.125 +8.70% 17
08/05/24 0.115 -8.00% 25
07/05/24 0.125 0.00% 21

Real-time Euronext Paris

Last update May 13, 2024 at 05:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer BNP Paribas BNP Paribas
BB2NB
ISINNLBNPFR1YEQ4
Date issued 19/02/2024
Strike 300
Maturity 20/09/2024 (130 Days)
Parity 40 : 1
Emission price 0.34
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.845
Lowest since issue 0.095
Delta0.15x
Omega 7.125
Premium49.41x
Gearing48.48x
Moneyness 0.6787
Difference Strike 96.4
Difference Strike %+32.13%
Spread 0.05
Spread %38.46%
Theoretical value 0.1050
Implied Volatility 52.02 %
Total Loss Probability 91.31 %
Intrinsic value 0.000000
Present value 0.1050
Break even 304.20 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Warrants
  3. BB2NB Warrant